Press Releases

TxCell SA (FR0010127662 – TXCL), a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Dr. Miguel Forte, Sr. VP Clinical Development and Regulatory Affairs,...

Patheon is to showcase its biologic, small molecule API development services and manufacturing capabilities for finished dosage forms at CPhI / ICSE Worldwide from Tuesday 7 October to Thursday 9 October in Paris Nord Villepinte, France. ...

Ireland-based Endo has made a $2.6bn cash-and-stock offer for Auxilium - which has been approved by the boards of both companies - that will add the latter's portfolio of testosterone replacement therapies to Endo fast-growing speciality pharma business. ...

Pharming to Directly Commercialise Ruconest in Austria Germany and NetherlandsBiotech company Pharming Group NV ("Pharming" or "the Company") (EURONEXT: PHARM) and Swedish Orphan Biovitrum AB (publ) or "Sobi" (SS: SOBI) today announced the amendment and extension of the Ruconest®...

Therapure Biopharma is appearing at the upcoming BioProcess International Conference & Exhibition. The company can be found at booth number 818. The event takes place from Monday 20 October to Thursday 23 October at Hynes Convention...

Boehringer Ingelheim Pharmaceuticals has introduced Striverdi Respimat (olodaterol) inhalation spray 5µg in the US market. Striverdi Respimat is indicated to treat airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic ...

Eyeforpharma, London, September 2014: Mary Baker, immediate past President of the European Brain Council, believes that pharma companies are focusing too much on patient centricity and instead, should widen their focus to include the whole...